Porton Pharma Solutions Ltd.
Porton Pharma Solutions Ltd. (China) holds 25 active US FDA Type II Drug Master Files and 2 inactive, has DMF or CEP filings on record for 21 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Porton Pharma Solutions Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/porton-pharma-solutions-ltd
Overview
Porton Pharma Solutions Ltd. is a leading contract development and manufacturing organization (CDMO) based in China. The company provides high-quality and efficient pharmaceutical services to global pharmaceutical companies, focusing on custom synthesis and process development solutions.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Porton Pharma Solutions Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Porton Pharma Solutions Ltd. holds 25 active (27 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- DAROLUTAMIDEActive2026-07-31
- RIMEGEPANT SULFATE (NON-STERILE)Active2025-06-25
- ABEMACICLIB DRUG SUBSTANCE (NON-STERILE)Active2025-05-27
- VENETOCLAXActive2025-04-10
- NIRAPARIB TOSYLATE MONOHYDRATEActive2025-03-17
- (S)-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRIMIDINE-6-CARBOXYLIC ACIDActive2025-03-16
- DOUTEGRAVIR SODIUM DRUG SUBSTANCE (MON-STERILE)Active2024-10-18
- VONOPRAZAN FUMARATEActive2024-10-14
- PHLOROGLUCINOL DIHYDRATEActive2024-09-24
- TRIMETHYLPHLOROGLUCINOL DRUG SUBSTANCE (NON-STERILE)Active2024-09-24
- SODIUM (S)-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRIMIDINE-6-CARBOXYLATEActive2024-09-13
- BALOXAVIR MARBOXILActive2024-09-05
- VIBEGRONActive2024-08-01
- RELUGOLIXActive2024-06-14
- ALECTINIB HYDROCHLORIDEActive2024-06-13
- ISAVUCONAZONIUM SULFATE API, NON-STERILE DRUG SUBSTANCEActive2023-11-10
- DAPAGLIFLOZINActive2023-10-16
- DEXRAZOXANEActive2023-03-17
- NICOTINE (SYNTHETIC)Active2023-02-10
- SALMETEROL XINAFOATE APIActive2022-05-23
- BIS-THF-ALCOHOL CARBONATEActive2021-06-30
- DN SULFONAMIDEActive2021-05-19
- DARUNAVIR ETHANOLATEActive2019-04-22
- TIOPRONIN NON-STERILE BULK DRUGActive2015-06-01
- MEFLOQUINE HYDROCHLORIDEActive2001-05-04
- CANAGLIFLOZINInactive2024-03-20
- APALUTAMIDEInactive2023-11-02
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Porton Pharma Solutions Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Porton Pharma Solutions Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Porton Pharma Solutions Ltd.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.